Home >> Professional Blog
It has been a strong run for MiMedx Group. How strong? Its 3-year growth is better than both Facebook and Amazon, according to Fortune Magazine.
The Alpharetta-based biopharmaceutical paced a group of five Georgia businesses that made Fortune Magazine's Top 100 fastest growing companies of 2017. Also making the list: Intercontinental Continental Exchange, Ameris Bancorp, Ebix, and Gray Television. Ameris and Intercontinental Exchange made the two largest leaps, jumping 30 and 28 spots, respectively.
Fortune's 2017 list looks at the top three-year performers in revenues, profits, and stock returns. To qualify, a company had to be trading on a major U.S. stock exchange; report data in U.S. dollars; file quarterly reports with the SEC; have a minimum market capitalization of $250 million and a stock price of at least $5 on June 30, 2017; and have been trading continuously since June 30, 2014.
MiMedx, which is developing and marketing regenerative and therapeutic biologics, finished as the fifth fastest-growing company on Fortune's list, behind Natural Health Trends, Paycom Software, LendingTree and ABIOMED.
In August, MiMedx Group, Inc. (NASDAQ: MDXG) signed an agreement to divest the company's subsidiary, Stability Biologics LLC, back to its original stockholders. The company the transition into a biopharmaceutical company was an impetus for the divestiture initiative.